$1.58
0.04[2.60%]
At close: Apr 26
$1.58
0[0.00%]
After Hours: 5:43PM EDT
Lexicon Pharmaceuticals
(NASDAQ:LXRX)Latest News for Lexicon Pharmaceuticals Stock (NASDAQ:LXRX)
Lexicon Pharmaceuticals Stock (NASDAQ: LXRX)
Categories: All
Tuesday, April 23, 2024
Monday, April 22, 2024
Thursday, April 11, 2024
Wednesday, March 27, 2024
Tuesday, March 12, 2024
- Lexicon Pharmaceuticals, Inc. Announces New Post Hoc Analysis Of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment In Patients With Type 1 Diabetes And Chronic Kidney DiseaseHappy Mohamed - Mar 12, 2024, 8:06AM
- ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionAvi Kapoor - Mar 12, 2024, 5:36AM
Monday, March 11, 2024
- Dow Turns Higher; GDS Holdings Shares ClimbAvi Kapoor - Mar 11, 2024, 2:44PM
- Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Mar 11, 2024, 1:41PM
- Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares JumpAvi Kapoor - Mar 11, 2024, 12:15PM
- Lexicon Pharmaceuticals: Q4 Earnings InsightsBenzinga Insights - Mar 11, 2024, 10:00AM
- Lexicon shares are trading higher after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.Benzinga Newsdesk - Mar 11, 2024, 7:22AM
- Lexicon Pharmaceuticals Q4 EPS $(0.20) Beats $(0.22) Estimate, Cash Position $170MBenzinga Newsdesk - Mar 11, 2024, 7:17AM
- Lexicon Announces Oversubscribed $250M Private Placement Of Equity SecuritiesBenzinga Newsdesk - Mar 11, 2024, 7:08AM
- Lexicon Preparing To Resubmit Sotagliflozin NDA For Type 1 Diabetes Following Feedback From FDABenzinga Newsdesk - Mar 11, 2024, 7:07AM
Tuesday, February 20, 2024
Thursday, February 15, 2024
Monday, January 08, 2024
Thursday, November 30, 2023
Tuesday, November 14, 2023
Sunday, November 12, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
Thursday, November 02, 2023
Wednesday, November 01, 2023
- Lexicon Pharmaceuticals Announces INPEFA Has Received Coverage From Express Scripts On Its Basic And High Performance Formularies For Commercially Insured PatientsBenzinga Newsdesk - Nov 1, 2023, 9:04AM
- Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 1, 2023, 8:07AM
- AMD, Yum China, Paycom Software And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionLisa Levin - Nov 1, 2023, 6:17AM
Tuesday, October 17, 2023
- Data From Two Studies Demonstrating Financial Impact Of INPEFA To Be Presented At The Academy Of Managed Care Pharmacy Nexus 2023 National MeetingBenzinga Newsdesk - Oct 17, 2023, 4:03PM
- Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Oct 17, 2023, 1:42PM